Whole Transcriptome Sequencing as a Diagnostic Tool for AML

Whole Transcriptome Sequencing as a Diagnostic Tool for AML

Explore the potential of whole transcriptome sequencing as a diagnostic tool for Acute Myeloid Leukemia (AML) in this 10-minute conference talk presented by Victória Tomaz at the Cancer Genomics Consortium (CGC) 2023 Annual Meeting. Gain insights into the latest advancements in cancer genomics and their application in improving diagnostic accuracy for AML patients. Learn how this cutting-edge sequencing technique can help identify underlying genomic alterations, potentially leading to more personalized and effective treatment strategies. Discover the CGC's commitment to promoting best practices in clinical cancer genomics and their vision of ensuring accurate diagnoses for all cancer patients.